The Lancet· Megan E Daly, Charles B Simone, Mary W Redman, Ming-Hui Hsieh, Paul J Hesketh, Chen Hu, Arta M Monjazeb, Conor E Steuer, Apar K Ganti, Rojano Kashani, Jessica R Bauman, Josephine L Feliciano, James Moon, Kimberly Ku, Nguyet Le-Lindqwister, Andrew M Baschnagel, Sanjay Maraboyina, Garrett B Sherwood, Daniel Almquist, Kristin A Higgins, Jhanelle E Gray, Jeffrey D Bradley, Karen Kelly·· 25 天前精选评分51
阿特珠单抗联合立体定向放疗对比单纯放疗治疗高风险早期非小细胞肺癌的三期随机对照试验结果
[Articles] Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial
导读
SWOG/NRG S1914 三期试验显示，阿特珠单抗联合立体定向放疗对比单纯放疗未改善高风险早期非小细胞肺癌患者的总生存期，且联合治疗组报告了更多3级或以上不良事件。
来源：The Lancet · thelancet.com